Publication | Closed Access
Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis
36
Citations
29
References
2006
Year
InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseRheumatic DiseasesImmunologyCxcl16 LevelsPathologyChronic InflammationInflammatory MarkerAutoimmunityInflammatory Rheumatic DiseaseImmunotherapyMedicineRheumatoid Arthritis
| Year | Citations | |
|---|---|---|
Page 1
Page 1